Discover
CSTL
Castle Biosciences, Inc.
24.71
2 x 17.59
2 x 30.64
bid
ask
+
0.86
3.61%
2 @ 04:13 AM
24.84 +0.13 (0.54%)
| Ytd | -36.48% | |
| 1y | 21.48% |
23.86
day range
24.86
14.59
52 week range
44.28
| Open | 23.94 | Prev Close | 23.85 | Low | 23.86 | High | 24.86 | Mkt Cap | 749.45M |
| Vol | 311.26K | Avg Vol | 399.60K | EPS | -0.42 | P/E | N/A | Forward P/E | -13.54 |
| Beta | 0.98 | Short Ratio | 4.27 | Inst. Own | 94.50% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-03 | 50-d Avg | 21.74 | 200-d Avg | 28.70 | 1yr Est | 41.56 |
CSTL News
benzinga.com
Castle Biosciences Announces Published Study In 'Dermatology And Therapy' Showing DecisionDx-Melanom
Newly published prospective study shows DecisionDx-Melanoma's i31-SLNB test result more accurate
prnewswire.com
DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forg
Newly published prospective study shows DecisionDx-Melanoma's i31-SLNB test result more accurately i
benzinga.com
This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday
Top Wall Street analysts changed outlook on top names. See all changes incl. upgrades, downgrades &a
benzinga.com
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday
Wall Street analysts change outlook on top names, with downgrades and initiations. See analyst ratin
benzinga.com
This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For
Analysts changed outlook on top names, including Intel and Arrow Financial. See ratings page. TNXP s
benzinga.com
Roth Capital Initiates Coverage On Castle Biosciences with Buy Rating, Announces Price Target of $40
Roth Capital analyst Max Masucci initiates coverage on Castle Biosciences (NASDAQ:CSTL) with a Bu